Generate a tailored SOP for Dr. Hanna Barriga. Improve your application with a focused, well-structured draft.
Hanna Barriga is an Associate Professor at KTH Royal Institute of Technology, specializing in the Division of Nanobiotechnology within the Department of Protein Science. Her research focuses on Precision Nanomedicine Engineering and the Personalised Medicine group, where she employs a multidisciplinary approach that integrates biology, physics, and chemistry to enhance understanding of nanoscale structures and their dynamics in biological processes. The primary objective of her group is to harness this information to accelerate the development and generation of engineered nanomedicines. Key areas of focus include nanoscale engineering, improved disease understanding, and performance validation of nanomedicines. By combining large datasets with single particle analysis, she aims to elucidate how disease impacts the performance of nanomedicines and to engineer superior delivery technologies at the nanoscale. A significant aspect of her research involves the utilization of large-scale research infrastructure, such as X-rays and neutrons Cryo EM, which enables the characterization of nanoscale structures and provides mechanistic explanations to map the relationship between nanoscale structure and performance. Her long-term vision is to leverage multidisciplinary datasets to facilitate the rational design of nanomedicines tailored to specific diseases and patient needs.
Master's programs are organized under Schools; departments listed are units within these schools (e.g., EECS, ABE, CBH, ITM, SCI).